Fosså SD - Search Results

1

Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).

Fosså SD, Harland SJ, Kaye SB, Raghavan D, Russell JM, Parmar MK, Uscinska BM, Wood R. Fosså SD, et al. Br J Urol. 1992 Aug;70(2):161-8. doi: 10.1111/j.1464-410x.1992.tb15696.x. Br J Urol. 1992. PMID: 1393439 Clinical Trial.

2

Carcinoma of the renal pelvis. Experience of 80 cases.

Raabe NK, Fosså SD, Bjerkehagen B. Raabe NK, et al. Among authors: fossa sd. Scand J Urol Nephrol. 1992;26(4):357-61. doi: 10.3109/00365599209181226. Scand J Urol Nephrol. 1992. PMID: 1292073

3

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

Mead GM, Stenning SP, Parkinson MC, Horwich A, Fossa SD, Wilkinson PM, Kaye SB, Newlands ES, Cook PA. Mead GM, et al. Among authors: fossa sd. J Clin Oncol. 1992 Jan;10(1):85-94. doi: 10.1200/JCO.1992.10.1.85. J Clin Oncol. 1992. PMID: 1309383

4

High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials Group.

Stoter G, Akdas A, Fosså SD, Kaye SB, van Groeningen CJ, Renard J, van Glabbeke M. Stoter G, et al. Among authors: fossa sd. Ann Oncol. 1992 Jul;3(7):577-8. doi: 10.1093/oxfordjournals.annonc.a058266. Ann Oncol. 1992. PMID: 1323325 Free article. Clinical Trial.

5

Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment.

Fosså SD, Paus E, Lindegaard M, Newling DW. Fosså SD, et al. Br J Urol. 1992 Feb;69(2):175-9. doi: 10.1111/j.1464-410x.1992.tb15491.x. Br J Urol. 1992. PMID: 1371425

6

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study.

Fosså SD, Martinelli G, Otto U, Schneider G, Wander H, Oberling F, Bauer HW, Achtnicht U, Holdener EE. Fosså SD, et al. Ann Oncol. 1992 Apr;3(4):301-5. doi: 10.1093/oxfordjournals.annonc.a058185. Ann Oncol. 1992. PMID: 1390305 Free article. Clinical Trial.

7

DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report.

Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fosså SD. Jacobsen AB, et al. Among authors: fossa sd. Eur Urol. 1992;22(4):316-22. doi: 10.1159/000474779. Eur Urol. 1992. PMID: 1490510

8

Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group.

Fosså SD, Droz JP, Pavone-Macaluso MM, Debruyne FJ, Vermeylen K, Sylvester R. Fosså SD, et al. Eur J Cancer. 1992;28A(4-5):878-80. doi: 10.1016/0959-8049(92)90139-s. Eur J Cancer. 1992. PMID: 1524914 Clinical Trial.

9

Cisplatin and 5-fluorouracil in advanced cancer of the penis.

Shammas FV, Ous S, Fossa SD. Shammas FV, et al. Among authors: fossa sd. J Urol. 1992 Mar;147(3):630-2. doi: 10.1016/s0022-5347(17)37327-5. J Urol. 1992. PMID: 1538445

10

Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer.

Fosså SD, Ous S, Espetveit S, Langmark F. Fosså SD, et al. Scand J Urol Nephrol. 1992;26(2):131-8. doi: 10.1080/00365599.1992.11690444. Scand J Urol Nephrol. 1992. PMID: 1626202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

936 results

Search Page

Filters